Evidence-based medicine

Mytonomy Cloud for Healthcare Validated Through Oracle Health Developer Program

Retrieved on:

Wednesday, May 3, 2023

Cloud, Software as a service, Evidence-based medicine, Nursing, Health care, FHIR, Rehabilitation, Digital health, Patient, EHR, UX, API, Health, Oracle Health Sciences

BETHESDA, Md., May 3, 2023 /PRNewswire-PRWeb/ -- Mytonomy, Inc., a leading enterprise SaaS solution for video-based patient education and engagement, announced Mytonomy Cloud for Healthcare has been validated and connects to Oracle Health's electronic health record (EHR). The developer program, named Code, includes a validation process that includes security, operational, functional, and UX reviews of a third-party application's connection to the EHR via FHIR APIs. Mytonomy now can provide health systems with video-based patient education directly within the EHR and help eliminate additional steps in providers' workflows.

Key Points:

BETHESDA, Md., May 3, 2023 /PRNewswire-PRWeb/ -- Mytonomy, Inc. , a leading enterprise SaaS solution for video-based patient education and engagement, announced Mytonomy Cloud for Healthcare has been validated and connects to Oracle Health's electronic health record (EHR).
Mytonomy now can provide health systems with video-based patient education directly within the EHR and help eliminate additional steps in providers' workflows.
"With our developer program, we're working toward making healthcare more open and connected than ever before."
"Providers can assign content to patients based on rules, with patient-level viewership being written back to Oracle Health," said Vinay Bhargava, Mytonomy President and Co-founder.

QIAGEN welcomes U.S. Preventive Services Task Force reaffirmation for latent TB screening in populations at increased risk

Retrieved on:

Wednesday, May 3, 2023

Venlo, the Netherlands, and Germantown, Maryland, May 03, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it welcomed the U.S. Preventive Services Task Force (USPSTF) reaffirming a previously issued recommendation for latent tuberculosis infection (LTBI) screening by primary care physicians in populations at increased risk.

Key Points:

Venlo, the Netherlands, and Germantown, Maryland, May 03, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it welcomed the U.S. Preventive Services Task Force (USPSTF) reaffirming a previously issued recommendation for latent tuberculosis infection (LTBI) screening by primary care physicians in populations at increased risk.
The USPSTF recommendations referred to QuantiFERON-TB Gold Plus (QFT-Plus) from QIAGEN as reliable in screening.
It also suggested that interferon gamma release assays (IGRAs) like QFT-Plus may have advantages in certain patient populations over the tuberculin skin test (TST) in a wider group of people at risk for latent TB infection.
This ongoing recommendation from the USPSTF supports the continued use of QuantiFERON-TB Gold Plus as part of the global fight against TB.

Health Equity Expert Winston Wong Joins CDC Foundation Board of Directors

Retrieved on:

Wednesday, April 19, 2023

ATLANTA, April 19, 2023 /PRNewswire/ -- Winston Wong, MD, MS, scholar-in-residence at the UCLA Kaiser Permanente Center for Health Equity, has been elected to a five-year term on the board of directors of the CDC Foundation.

Key Points:

ATLANTA, April 19, 2023 /PRNewswire/ -- Winston Wong, MD, MS, scholar-in-residence at the UCLA Kaiser Permanente Center for Health Equity, has been elected to a five-year term on the board of directors of the CDC Foundation.
Throughout his 40-year career with roles in clinical medicine, health administration, data and policy development and healthcare philanthropy, Wong has been dedicated to improving health equity and addressing socioeconomic and racial/ethnic disparities in health.
During his time at Kaiser Permanente, Wong developed partnerships with communities to address health equity through enhancing population health and the dissemination of evidence-based medicine.
At the National Academies of Sciences, Engineering, and Medicine, Wong chairs the Roundtable on Health Equity and has served on the Board of Population Health and Public Health Practice.

ClinFocus Inc presents at the 2023 Europe Interchange Conference on Real World Data

Retrieved on:

Tuesday, April 18, 2023

Real-World Evidence, Clinical Data Interchange Standards Consortium, Evidence-based medicine, Clinical trial, Conduct, Science and technology in Asia, Doctor of Philosophy, Address, Digital technology, RWE, CDISC, SSA, Pharmaceutical industry

ATLANTA, April 18, 2023 /PRNewswire/ -- ClinFocus Inc is delighted to announce that Obiageli Onwusaka Ph.D. will be speaking at the Clinical Data Interchange Standards Consortium (CDISC) Europe 2023 Interchange conference on the topic-Leveraging Real-World Evidence (RWE) to Address gaps in the Design and Conduct of Clinical Trials in Africa: Strategies for Optimizing Patient Recruitment and Retention.

Key Points:

ATLANTA, April 18, 2023 /PRNewswire/ -- ClinFocus Inc is delighted to announce that Obiageli Onwusaka Ph.D. will be speaking at the Clinical Data Interchange Standards Consortium (CDISC) Europe 2023 Interchange conference on the topic-Leveraging Real-World Evidence (RWE) to Address gaps in the Design and Conduct of Clinical Trials in Africa: Strategies for Optimizing Patient Recruitment and Retention.
On 26th April 2023, during Session 4: (Track A- Real-World Data) at Árni Magnússon Gade 2 - 4, København, Denmark, Obiageli Onwusaka, PhD.
Global data analysis of a Clinical Trials Database reported 55% of trials were terminated due to low accrual rate.
The presentation will explore best practice methods for improving patient engagement during clinical trials by using data gathered from real-world settings.

ClinFocus Inc presents at the 2023 Europe Interchange Conference on Real World Data

Retrieved on:

Tuesday, April 18, 2023

ATLANTA, April 18, 2023 /PRNewswire/ -- ClinFocus Inc is delighted to announce that Obiageli Onwusaka Ph.D. will be speaking at the Clinical Data Interchange Standards Consortium (CDISC) Europe 2023 Interchange conference on the topic-Leveraging Real-World Evidence (RWE) to Address gaps in the Design and Conduct of Clinical Trials in Africa: Strategies for Optimizing Patient Recruitment and Retention.

Key Points:

ATLANTA, April 18, 2023 /PRNewswire/ -- ClinFocus Inc is delighted to announce that Obiageli Onwusaka Ph.D. will be speaking at the Clinical Data Interchange Standards Consortium (CDISC) Europe 2023 Interchange conference on the topic-Leveraging Real-World Evidence (RWE) to Address gaps in the Design and Conduct of Clinical Trials in Africa: Strategies for Optimizing Patient Recruitment and Retention.
On 26th April 2023, during Session 4: (Track A- Real-World Data) at Árni Magnússon Gade 2 - 4, København, Denmark, Obiageli Onwusaka, PhD.
Global data analysis of a Clinical Trials Database reported 55% of trials were terminated due to low accrual rate.
The presentation will explore best practice methods for improving patient engagement during clinical trials by using data gathered from real-world settings.

Atropos Health Launches in AWS Marketplace and Joins the AWS Partner Network

Retrieved on:

Monday, April 17, 2023

PALO ALTO, Calif., April 17, 2023 /PRNewswire/ -- Atropos Health, a leader in generating personalized real-world evidence at the point and pace of care, today announced its services are now available to purchase in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors (ISVs) that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). In addition to being listed on AWS Marketplace, Atropos Health has also joined the AWS Partner Network (APN), a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and sell customer offering. Through the APN, Atropos Health can deliver scalable and reliable services to healthcare organizations on AWS.

Key Points:

In addition to being listed on AWS Marketplace, Atropos Health has also joined the AWS Partner Network (APN), a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and sell customer offering.
Through the APN, Atropos Health can deliver scalable and reliable services to healthcare organizations on AWS.
By offering its services in AWS Marketplace and becoming a member of the APN, Atropos Health is increasing access to relevant and timely real-world evidence.
This idea evolved into the Green Button Consult Service Atropos Health offers to clinicians and researchers today (See here ).

Agfa Healthcare Applauded by Frost & Sullivan for Improving Workflow Effectiveness, Healthcare System Quality, and Customer Value

Retrieved on:

Thursday, April 13, 2023

Informatics, Enterprise, Enterprise imaging, IHR, Evidence-based medicine, Information technology, Research, Acquisition, SAN, Health, Growth, Ecosystem, Frost, Nursing, Risk management

SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-based requirements and, based on its research, recognizes Agfa HealthCare with the 2023 Global Customer Value Leadership Award. The company uniquely leverages its expertise and incorporates customer feedback into its product roadmap to address the growing, fast-evolving global needs and customer-specific challenges. Its unified Enterprise Imaging platform helps clients manage resource allocation, improve productivity, access centralized security and data privacy, and provide clinical confidence with patient-centric contextual intelligence. The technology satisfies multispecialty needs and securely standardizes workflows to enable smooth collaboration between departments and geographical locations.

Key Points:

SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-based requirements and, based on its research, recognizes Agfa HealthCare with the 2023 Global Customer Value Leadership Award.
Agfa HealthCare's Enterprise Imaging platform reduces organizational complexity and redundancy, helping healthcare providers achieve their clinical, operational, and business strategies from product development to implementation.
Every remote monitoring system notifies Agfa HealthCare of potential issues, allowing it to remedy problems before they arise."
Its overall customer-first approach offers immense value to existing and new customers," added Manuel Albornoz, best practices research analyst at Frost & Sullivan.

Agfa Healthcare Applauded by Frost & Sullivan for Improving Workflow Effectiveness, Healthcare System Quality, and Customer Value

Retrieved on:

Thursday, April 13, 2023

Informatics, Enterprise, Enterprise imaging, IHR, Evidence-based medicine, Information technology, Research, Acquisition, SAN, Health, Growth, Ecosystem, Frost, Nursing, Risk management

SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-based requirements and, based on its research, recognizes Agfa HealthCare with the 2023 Global Customer Value Leadership Award. The company uniquely leverages its expertise and incorporates customer feedback into its product roadmap to address the growing, fast-evolving global needs and customer-specific challenges. Its unified Enterprise Imaging platform helps clients manage resource allocation, improve productivity, access centralized security and data privacy, and provide clinical confidence with patient-centric contextual intelligence. The technology satisfies multispecialty needs and securely standardizes workflows to enable smooth collaboration between departments and geographical locations.

Key Points:

SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-based requirements and, based on its research, recognizes Agfa HealthCare with the 2023 Global Customer Value Leadership Award.
Agfa HealthCare's Enterprise Imaging platform reduces organizational complexity and redundancy, helping healthcare providers achieve their clinical, operational, and business strategies from product development to implementation.
Every remote monitoring system notifies Agfa HealthCare of potential issues, allowing it to remedy problems before they arise."
Its overall customer-first approach offers immense value to existing and new customers," added Manuel Albornoz, best practices research analyst at Frost & Sullivan.

Global Advanced Dressings and Closure Products Wound Care Market Report to 2026: Continuing Adoption of Moist Wound Healing Principles by Clinicians Drives Growth - ResearchAndMarkets.com

Retrieved on:

Tuesday, April 11, 2023

Medical Supplies, Health, Science, COVID-19, Knowledge, Wound healing, Prevalence, Evidence-based medicine, Tissue engineering, Nursing

The "Wound Care: Advanced Dressings and Closure Products" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Wound Care: Advanced Dressings and Closure Products" report has been added to ResearchAndMarkets.com's offering.
Over the past 25 years, there has been an explosion of knowledge regarding the basic science of wound healing and a trend toward more evidence-based medicine.
In 2021, global sales of advanced wound care products totalled nearly $7.8bn, with advanced wound closure products accounting for more than half of sales and advanced dressings accounting for the remainder.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for advanced wound dressings and closure products; these include alginate, film, foam, hydrocolloid, hydrogel, wound contact layer, and antimicrobial dressings, as well as surgical sealants/glues, energy-based wound closure products, and negative pressure wound therapy products.

Global Wound Care: Tissue-Engineered Skin Replacements and Wound Modulators Market Report 2023: Featuring AbbVie, Integra LifeSciences, MiMedx, Organogenesis, Smith+Nephew & Wright Medical - ResearchAndMarkets.com

Retrieved on:

Wednesday, April 5, 2023

Health, Biotechnology, Obesity, Enzyme, Neuropeptide, Prevalence, Evidence-based medicine, Diabetes, COVID-19, Skin, Ageing, Science, Hormone, Incidence, Tissue engineering, Knowledge, B cell, Wound healing, Pharmaceutical industry

The "Global Wound Care: Tissue-Engineered Skin Replacements and Wound Modulators Market - 2023 Report" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Global Wound Care: Tissue-Engineered Skin Replacements and Wound Modulators Market - 2023 Report" report has been added to ResearchAndMarkets.com's offering.
Over the past two decades, there has been an explosion of knowledge regarding the basic science of wound healing and a trend toward more evidence-based medicine.
In 2021, global sales of tissue-engineered skin replacements and wound modulators totaled more than $1.5bn, with skin replacements accounting for the vast majority of the market.
Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World.